LONDON, July 2 (Reuters) - AstraZeneca Plc shares rose nearly 5 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and ...
LONDON, May 18 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Friday U.S. regulators had approved Seroquel XR, a once-daily version of its blockbuster schizophrenia drug. Seroquel is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results